sk&f 82958 has been researched along with apomorphine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hipkens, SB; Yurek, DM | 1 |
Chang, JP; Peter, RE; Wong, AO | 1 |
Cory-Slechta, DA; Pokora, MJ; Richfield, EK | 1 |
Cory-Slechta, DA; McCoy, L; Richfield, EK | 1 |
Flik, G; Lamers, AE; Ter Brugge, PJ; Wendelaar Bonga, SE | 1 |
Kuno, S | 1 |
Miller, DK; Nation, JR | 1 |
Féger, J; Hassani, OK | 1 |
Baik, JH; Borrelli, E; Dierich, A; LeMeur, M; Piazza, PV; Picetti, R; Rougé-Pont, F; Usiello, A | 1 |
Finlay, HE; Martin, LP; Stellar, JR; Waszczak, BL; Zahr, N | 1 |
Geyer, MA; Lehmann-Masten, V; Low, MJ; Otero-Corchon, V; Ralph-Williams, RJ | 1 |
Glavan, G; Zivin, M | 1 |
Platt, DM; Rowlett, JK; Spealman, RD; Yao, WD | 1 |
Gewirtz, JC; Radke, AK | 1 |
Bini, V; Bortolato, M; Devoto, P; Frau, R; Pillolla, G; Tambaro, S | 1 |
Amodeo, LR; Crawford, CA; Der-Ghazarian, T; Gonzalez, AE; Gutierrez, A; Humphrey, DE; McDougall, SA; Valentine, JM; Widarma, CB | 1 |
Ikeda, K; Ikejiri, M; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Ogi, Y | 1 |
17 other study(ies) available for sk&f 82958 and apomorphine
Article | Year |
---|---|
Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Histocytochemistry; Injections; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Stereotyped Behavior; Substantia Nigra | 1994 |
In vitro and in vivo evidence that dopamine exerts growth hormone-releasing activity in goldfish.
Topics: Administration, Oral; Animals; Apomorphine; Benzazepines; Dopamine; Dopamine Agents; Goldfish; Growth Hormone; Growth Hormone-Releasing Hormone; Receptors, Dopamine; Seasons; Somatostatin | 1993 |
Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
Topics: Administration, Oral; Animals; Apomorphine; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kinetics; Lead; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Organometallic Compounds; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1996 |
Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958.
Topics: Animals; Apomorphine; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Drug Administration Schedule; Lead; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Time Factors; Tissue Distribution | 1997 |
Acid stress induces a D1-like dopamine receptor in pituitary MSH cells of Oreochromis mossambicus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acclimatization; alpha-MSH; Animals; Apomorphine; Benzazepines; Dopamine; Dopamine Agonists; Hydrogen-Ion Concentration; Male; Pituitary Gland; Quinpirole; Receptors, Dopamine D1; Stress, Physiological; Tilapia | 1997 |
Differential therapeutic effects of dopamine D1 and D2 agonists in MPTP-induced parkinsonian monkeys: clinical implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Dopamine Agonists; Macaca fascicularis; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1997 |
The effects of cadmium contamination on the discriminative stimulus properties of cocaine and related drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Body Weight; Cadmium Chloride; Cocaine; Dextroamphetamine; Discrimination, Psychological; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Drug Tolerance; Eating; Male; Piperazines; Procaine; Quinpirole; Rats; Rats, Sprague-Dawley | 1999 |
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Topics: Adrenergic Agents; Animals; Apomorphine; Benzazepines; Dopamine Agonists; Male; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Thalamic Nuclei | 1999 |
Distinct functions of the two isoforms of dopamine D2 receptors.
Topics: Animals; Apomorphine; Benzazepines; Catalepsy; Chimera; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis; Protein Isoforms; Quinpirole; Receptors, Dopamine D2; Signal Transduction; Spiperone; Synapses | 2000 |
Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Benzamides; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Extracellular Space; Male; Membrane Potentials; Microinjections; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 2002 |
Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; Genotype; Heterozygote; Homozygote; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reflex, Startle | 2002 |
Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Brain; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Female; Gene Expression; Gene Expression Regulation; In Situ Hybridization; Levodopa; Oxidopamine; Parkinsonian Disorders; Protein Isoforms; Rats; Rats, Wistar; RNA, Messenger; Rotation; Substantia Nigra; Synaptotagmins; Time Factors; Tyrosine 3-Monooxygenase | 2005 |
Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Cocaine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Female; Heroin; Injections, Intravenous; Macaca mulatta; Male; Narcotics; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Reinforcement, Psychology; Self Administration; Vasoconstrictor Agents | 2007 |
Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anxiety; Apomorphine; Benzazepines; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Male; Morphine; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reflex, Startle; Substance Withdrawal Syndrome | 2012 |
Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
Topics: 5-alpha Reductase Inhibitors; Animals; Apomorphine; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Finasteride; Haloperidol; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinpirole; Sensory Gating; Stereotyped Behavior | 2013 |
Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.
Topics: Aging; Alkylating Agents; Animals; Apomorphine; Benzazepines; Caudate Nucleus; Dimethyl Sulfoxide; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Lisuride; Male; Motor Activity; Putamen; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Weaning | 2014 |
The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Topics: Acetamides; Animals; Apomorphine; Benzamides; Benzazepines; Benzopyrans; Blinking; Callithrix; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Male; Models, Animal; Oxazines; Piperazines; Pyridines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4 | 2016 |